Delivery Order SPE2DB24D3013-SPE2DB25FFLCB
Award Date 4/22/25
Potential Completion Date 4/23/25
Potential Value $7.7K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $9,132.72 to AmerisourceBergen Drug Corp for TRELEGY ELLIPTA 200-62.5-25, a combination inhalation medication used to treat chronic obstructive pulmonary disease. The contract, awarded on November 6, 2025, with an ultimate completion date of November 7, 2025, is structured as a firm fixed-price delivery order with no set-aside designation, indicating open and competitive procurement. The place of performance is...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,092.99 to AmerisourceBergen Drug Corp for TRELEGY ELLIPTA 100-62.5-25 60S, a combination inhalation therapy medication used to treat chronic obstructive pulmonary disease. This competitively awarded, firm fixed-price delivery order was issued on November 10, 2025, with an ultimate completion date of November 12, 2025. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency (DLA) awarded a $16,409.89 firm fixed price delivery order to AmerisourceBergen Drug Corp for TRELEGY ELLIPTA 100-62.5-25 60S, a combination inhalation medication used to treat chronic obstructive pulmonary disease. The award, issued on July 22, 2025, is a non-set-aside competitive procurement with an ultimate completion date of July 23, 2025. Performance will be executed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery...
- The Defense Logistics Agency (DLA) awarded a $22,946.07 delivery order to AmerisourceBergen Drug Corp for TRELEGY ELLIPTA 200-62.5-25, a combination inhaler medication used to treat chronic obstructive pulmonary disease. The contract was competitively awarded without set-aside provisions and carries a firm fixed price structure with an ultimate completion date of September 9, 2025. Performance will be executed from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $5,688.69 to AmerisourceBergen Drug Corp for TRELEGY ELLIPTA 100-62.5-25, a combination inhalation medication used to treat chronic obstructive pulmonary disease. This competitively awarded, firm fixed-price delivery order was issued on October 28, 2025, with an ultimate completion date of October 29, 2025. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. No set-aside...
- The Defense Logistics Agency awarded a $26,582.49 firm fixed-price delivery order to AmerisourceBergen Drug Corp for TRELEGY ELLIPTA 100-62.5-25 60S, a combination inhalation medication used to treat chronic obstructive pulmonary disease. The contract was competitively awarded with no set-aside designation and is set for completion by August 4, 2025. This delivery order will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,131.60 to AmerisourceBergen Drug Corp for TRELEGY ELLIPTA 200-62.5-25 (60-count), a combination inhaler medication used to treat chronic obstructive pulmonary disease. Awarded on October 27, 2025, with an ultimate completion date of October 28, 2025, this firm fixed-price delivery order was competitively awarded with no set-aside designation. The contract will be performed at AmerisourceBergen's corporate office location in...
- The Defense Logistics Agency awarded a delivery order valued at $8,409.03 to AmerisourceBergen Drug Corp for TRELEGY ELLIPTA 100-62.5-25 60S, a combination inhalation powder medication used to treat chronic obstructive pulmonary disease. The competitively awarded, firm fixed-price delivery order was placed on August 8, 2025, with an ultimate completion date of August 11, 2025. Performance will be executed from AmerisourceBergen's corporate office located in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $8,417.46 for TRELEGY ELLIPTA 100-62.5-25 60S, a combination inhalation powder medication used in the treatment of chronic obstructive pulmonary disease. Issued on August 5, 2025, with completion targeted for August 6, 2025, this firm fixed-price delivery order represents a routine pharmaceutical procurement under a competitive, non-set-aside award. The contract will be performed at AmerisourceBergen's...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $8,350.27 to AmerisourceBergen Drug Corp for TRELEGY ELLIPTA 200-62.5-25, a combination inhalation powder medication used to treat chronic obstructive pulmonary disease. This firm fixed-price delivery order was competitively awarded without set-aside restrictions and is scheduled for completion by August 26, 2025. The award was processed on August 25, 2025, with performance taking place at AmerisourceBergen's corporate...